Imago BioSciences Inc.

05/09/2022 | Press release | Distributed by Public on 05/09/2022 08:02

Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Study of Bomedemstat in Combination with Atezolizumab in Small Cell Lung Cancer - Form 8-K